(S (NP (PRP We)) (VP (VBD discovered) (NP (NP (JJ secular) (NN trend) (NN bias)) (PP (IN in) (NP (DT a) (NN drug) (NN effectiveness) (NN study)))) (PP (IN for) (NP (DT a) (ADJP (RB recently) (VBN approved)) (NN drug)))) (. .))
(S (S (NP (PRP We)) (VP (VBD compared) (NP (NP (NN treatment) (NNS outcomes)) (PP (IN between) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (DT the) (ADJP (RB newly) (VBN approved)) (NN drug)))))))))) (CC and) (S (NP (NNS patients)) (VP (VBD exposed) (PP (IN to) (NP (DT the) (JJ standard) (NN treatment))))) (. .))
(S (NP (DT All) (NNS patients)) (VP (VBD diagnosed) (SBAR (IN after) (S (NP (NP (DT the) (JJ new) (NN drug) (POS 's)) (NN approval) (NN date)) (VP (VBD were) (VP (VBN considered)))))) (. .))
(S (NP (PRP We)) (VP (VBD built) (NP (DT a) (NN machine)) (S (VP (VBG learning) (NP (JJ causal) (NN inference) (NN model)) (S (VP (TO to) (VP (VB determine) (S (NP (JJ patient) (NNS subpopulations)) (ADJP (JJ likely) (S (VP (TO to) (VP (VB respond) (ADVP (RB better)) (PP (IN to) (NP (DT the) (ADJP (RB newly) (VBN approved)) (NN drug)))))))))))))) (. .))
(S (PP (IN After) (S (VP (VBG identifying) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ secular) (NN trend) (NN bias)) (PP (IN in) (NP (PRP$ our) (NNS data))))))))) (, ,) (NP (PRP we)) (VP (VBD attempted) (S (VP (TO to) (VP (VB adjust) (PP (IN for) (NP (NP (DT the) (NN bias)) (PP (IN in) (NP (CD two) (JJ different) (NNS ways))))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBD matched) (NP (NNS patients)) (PP (IN on) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS days)) (PP (IN from) (NP (NP (DT the) (JJ new) (NN drug) (POS 's)) (NN approval) (NN date))))))) (SBAR (WHNP (WDT that)) (S (NP (NP (NP (DT the) (NN patient) (POS 's)) (NN treatment)) (PRN (-LRB- -LRB-) (NP (JJ new) (CC or) (JJ standard)) (-RRB- -RRB-))) (VP (VBD began))))) (. .))
(S (ADVP (RB Second)) (, ,) (NP (PRP we)) (VP (VBD included) (NP (DT a) (NN covariate)) (PP (IN in) (NP (DT the) (NN model))) (PP (IN for) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS days)) (PP (IN between) (NP (NP (DT the) (NN date)) (PP (IN of) (NP (NP (NN approval)) (PP (IN of) (NP (NP (DT the) (JJ new) (NN drug)) (CC and) (NP (DT the) (NML (NN treatment) (PRN (-LRB- -LRB-) (NP (JJ new) (CC or) (JJ standard)) (-RRB- -RRB-))) (NN start) (NN date))))))))))))) (. .))
(S (NP (DT Neither) (NN approach)) (ADVP (RB completely)) (VP (VBD mitigated) (NP (DT the) (NN bias))) (. .))
(S (NP (JJ Residual) (NN bias)) (NP (PRP we)) (VP (VBP attribute) (PP (IN to) (NP (NP (NNS differences)) (PP (IN in) (NP (NP (JJ patient) (NN disease) (NN severity)) (CC or) (NP (JJ other) (ADJP (JJ unmeasured) (JJ patient)) (NNS characteristics))))))) (. .))
(S (SBAR (SINV (VBD Had) (NP (PRP we)) (VP (RB not) (VBD identified) (NP (NP (DT the) (JJ secular) (NN trend) (NN bias)) (PP (IN in) (NP (PRP$ our) (NNS data))))))) (, ,) (NP (DT the) (JJ causal) (NN inference) (NN model)) (VP (MD would) (VP (VB have) (VP (VBN been) (VP (VBN interpreted) (PP (IN without) (NP (NP (NN consideration)) (PP (IN for) (NP (DT this) (VBG underlying) (NN bias))))))))) (. .))
(S (S (VP (VP (VBG Being) (ADJP (JJ aware) (PP (IN of)))) (, ,) (VP (VBG testing) (PP (IN for))) (, ,) (CC and) (VP (VBG handling) (NP (JJ potential) (NN bias)) (PP (IN in) (NP (DT the) (NNS data)))))) (VP (VBZ is) (ADJP (JJ essential) (S (VP (TO to) (VP (VB diminish) (NP (DT the) (NN uncertainty)) (PP (IN in) (NP (NN AI) (NN modeling)))))))) (. .))
